Navigation Links
NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually
Date:12/8/2011

ZURICH, December 9, 2011 /PRNewswire/ --

NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System

Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports innovators, commissioners, and clinicians to speed up the development and use of innovations that will benefit the NHS.

Brian Winn, Head of the National Innovation Centre, explains, "Sequana Medical's ALFApump System is a revolutionary fluid management solution for patients with ascites which could save the NHS significant amounts of money by eliminating the costs associated with repeat medical interventions whilst significantly improving patients' Quality of Life."

The ALFApump System is indicated for the management of refractory and recurrent ascites due to liver cirrhosis, a condition where massive and uncontrolled fluid accumulation occurs in the abdominal cavity. The fully implantable battery powered pump system slowly removes ascites as it forms by transferring it to the bladder where it is eliminated through normal urination.  This condition affects around 3,000 people in the UK a year.

Rajiv Jalan, Professor of Hepatology, UCL, and Honorary Consultant, Royal Free Hospital, London, comments, "The ALFApump System is an exciting innovation in the care of refractory ascites patients for whom current treatment options are very limited."  

Patients are typically managed with large-volume paracentesis, an invasive procedure in which the ascites is drained over a number of hours through a large needle inserted in the abdomen.

Dr Farzana Malik, Vice President of Market Access at Sequana Medical explains, "I am delighted that the National Innovation Centre has recognized the considerable economic benefits to the NHS offered by the ALFApump System. This is a unique technology that provides significant benefits for patients, clinicians and the NHS."

The ALFApump System was granted CE Mark in July 2011 and is currently being launched in leading hepatology centres across Europe by Sequana Medical.

About Sequana Medical:

Sequana Medical is a Swiss medical device company dedicated to improving patient lives through innovative technologies to manage fluid within the body.

Contact:
Sequana Medical
Emily Woodward
Product Marketing Manager
Emily.woodward@sequanamedical.com
Tel: +41-44-446-5074
http://www.sequanamedical.com



'/>"/>
SOURCE Sequana Medical AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
2. New MediCare International Excess Options Give up to 50% Premium Discount
3. Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
4. Chindex International, Inc. to Present at the 22nd Annual Oppenheimer Healthcare Conference
5. National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week
6. National Influenza Vaccination Week is December 4 - 10, 2011
7. Bupa International Releases Health Guides to Hong Kong and Singapore
8. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
9. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
10. Tom Hall Named National Sales and Marketing Director for VR Laboratories
11. Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Feb. 5, 2016 Dehaier Medical Systems ... the "Company"), which develops, markets and sells medical ... China and international markets, today ... aims to concentrate the Company,s resources to develop ... business and to focus more on its major ...
(Date:2/5/2016)... HARROGATE, England , February 5, 2016 ... --> Today, VoicePower Ltd - The Speech Recognition People, ... has been deployed to improve patient care, reduce turnaround times and ... ,- Wirral CCG ,- VoicePower client since 2013 Challenge: ... Challenge: --> - Six doctors ,- Wirral ...
(Date:2/4/2016)... 4, 2016  Edwards Lifesciences Corporation (NYSE: EW ... heart disease and critical care monitoring, announced today that ... agreement with Morgan Stanley & Co. LLC to repurchase ... part of the Company,s previously authorized program to repurchase ... --> --> ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... 06, 2016 , ... US Sports Camps is proud to sponsor the Bay ... together top non-profit leaders, ultimate organizations, and coaches from around the US. The theme ... Disc Program Director of Youth and Education, describes this year YUCC as “an important ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown that building ... the frequency and level of relapse. , At the 2016 iaedp ... will explore the critical tasks of the recovery phase and beyond including relapse ...
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality ... lighter, sleeker next generation LYNX VR Indoor Trainer with multi-rider capability to an ... and manufacturing not only reduce the weight of the unit, they also enhance ...
(Date:2/5/2016)... ... 05, 2016 , ... The event is being held on April 7, 2016 ... Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and ... Parkinson’s disease and is the architect of this informative event to raise awareness and ...
(Date:2/5/2016)... York (PRWEB) , ... February 05, 2016 , ... Looking ... answer may be at the tips of your toes. Foot massage, whether administered by ... as pure comfort and relaxation. The American Board of Multiple Specialties in Podiatry ...
Breaking Medicine News(10 mins):